Company page

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc. is a public company traded under the ticker NAUT in the American market. The company has a market capitalization of approximately $214.76 million. Nautilus focuses on advancing biotechnology solutions, contributing to the development of innovative approaches in the field.